Natco Pharma Limited - 672564 - 04/08/2024 Natco Pharma Limited - 672564 - 04/08/2024 | FDA
Contents of warning letter is in public domain
In its response to the usfda Natco had volunteered to suspend drug production/supplies from kothur plant to US market which has been accepted and conveyed in the WL… this should be read in the context of companys disclosure to the bourses earlier on this subject… Here is hoping that the two strengths of Lenalidomide that it didn’t have dual clearance for( in the vizag facility) have been subsequently cleared since…
Subscribe To Our Free Newsletter |